Ascorbic/Glutathione Eye Solution Recalled for Sterility Concerns
Red Mountain Compounding Pharmacy is recalling an ascorbic/glutathione eye solution because FDA inspection identified concerns about sterility assurance during manufacturing.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving a sterile ophthalmic product where sterility assurance cannot be provided. Sterility defects in eye solutions pose serious infection risk, and the product is distributed to nearly 500 patients. Per the rubric, FDA Class II recalls are typically scored at 4 (Severe) when they involve products with inherent risk of serious harm.
Plain-English summary
Red Mountain Compounding Pharmacy, operating as First Royal Care Co. LLC, is recalling Ascorbic/Glutathione 1.25/1.25% Ophthalmic Solution (Rx only) due to lack of assurance of sterility. An FDA inspection identified concerns regarding the manufacturer's ability to ensure the product's sterility.
The affected product was distributed to approximately 494 patients and consumers who received prescriptions in Arizona, California, Florida, Minnesota, Montana, Texas, and Utah. All lots currently subject to recall remain within their expiration dates.
Patients currently using this eye solution should contact their healthcare provider or pharmacist for guidance. The risk associated with a non-sterile ophthalmic solution includes potential eye infection or other adverse effects if contamination is present.
The recalled product
- Product
- ASCORBIC/GLUTATHIONE 1.25/1.25% OPTH SOLN, Rx only, Red Mountain Compounding Rx
- Manufacturer
- First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
- Category
- Drug — Ophthalmic / Eye Solution
- Hazard
- sterility-assurance
- potential-infection
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all lots within expiry
Distribution
Distributed in 7 states:
- AZ
- CA
- FL
- MN
- MT
- TX
- UT
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27